← USPTO Patent Applications

ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT

Application US20260090995A1 Kind: A1 Apr 02, 2026

Assignee

ESTETRA SRL

Inventors

Séverine Francine Isabelle JASPART, Johannes Jan PLATTEEUW, Denny Johan Marijn VAN DEN HEUVEL

Abstract

The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of: 0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof; and75-99.9 wt. % of one or more pharmaceutically acceptable ingredients;the solid dosage unit comprising at least 100 μg of the estetrol component; and wherein the solid dosage unit can be obtained by a process comprising wet granulation of estetrol particles having a volume weighted average particle size of 2 μm to 50 μm. The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.

CPC Classifications

A61K 9/2095 A61K 9/0056 A61K 9/2027 A61K 9/2054 A61K 9/2059 A61K 9/2077 A61K 31/565 A61P 5/00 A61P 15/18 A61K 9/1623

Filing Date

2025-09-25

Application No.

19340502